Back

ENTRUST-AF PCI trial in context with other non-vitamin K antagonist oral anticoagulant trials in percutaneous coronary intervention practice

3 September 2019 (13:35 - 13:45)
Organised by:
Congress Presentation Part of: Antithrombotic therapy in atrial fibrillation patients undergoing PCI: where do we stand? Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Pascal Vranckx

Heart Centre Hasselt, Hasselt (Belgium)

5 More presentations in this session

Presentation thumbnail
Introduction
Professor F. Verheugt (Amsterdam, NL) Doctor M. Lettino (Monza, IT)
Video
Presentation thumbnail
Standard of care and current challenges in patients with atrial fibrillation undergoing percutaneous coronary intervention
Doctor M. Lettino (Monza, IT)
Slides
Presentation thumbnail
ENTRUST- AF PCI trial
Professor A. Goette (Paderborn, DE)
Presentation thumbnail
Panel discussion
Doctor M. Lettino (Monza, IT) Professor F. Verheugt (Amsterdam, NL)
Presentation thumbnail
Summary and conclusions
Professor F. Verheugt (Amsterdam, NL) Doctor M. Lettino (Monza, IT)

Access the full session

Session thumbnail
Antithrombotic therapy in atrial fibrillation patients undergoing PCI: where do we stand?

The Event

Event poster

ESC Congress 2019

3 September 2019 13:35 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Presentation
AF-CARE: “R” Rate and rhythm control
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources